To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

BoNT-A injection within ECRB demonstrates efficacy versus placebo for lateral epicondylitis

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
June 2018

BoNT-A injection within ECRB demonstrates efficacy versus placebo for lateral epicondylitis

Vol: 7| Issue: 6| Number:12| ISSN#: 2564-2537
Study Type:Randomized Trial
OE Level Evidence:1
Journal Level of Evidence:N/A

Short-Term Effect of Low-Dose, Electromyography-Guided Botulinum Toxin A Injection in the Treatment of Chronic Lateral Epicondylar Tendinopathy: A Randomized, Double-Blinded Study

J Bone Joint Surg Am. 2018 May 16;100(10):818-826

Contributing Authors:
A Creuzé H Petit M de Sèze

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

60 patients with lateral epicondylitis were randomized to an injection into the extensor carpi radialis brevis (ECRB) of either botulinum toxin type A (BoNT-A) or placebo. Patients were assessed after 30 and 90 days. The primary outcome was the rate of patients who experienced a minimum 50% reduction in pain on a visual analog scale. Additional outcomes investigated included the rate of patients w...

Join the Conversation

Please Login or Join to leave comments.